Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-10

Clinical Trial Update: Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections [Phase 3]

View source ↗

Summary

Phase 3 trial update on Cefepime-AAI101 for complicated urinary tract infections completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cefepime/AAI101

Snippet

Sponsor: Allecra | Conditions: Urinary Tract Infections | Phase 3 | Status: COMPLETED